Bal Pharma standalone net profit declines 38.83% in the September 2017 quarter
Sales decline 16.74% to Rs 54.55 crore
Net profit of Bal Pharma declined 38.83% to Rs 1.67 crore in the quarter ended September 2017 as against Rs 2.73 crore during the previous quarter ended September 2016. Sales declined 16.74% to Rs 54.55 crore in the quarter ended September 2017 as against Rs 65.52 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales54.5565.52 -17 OPM %10.109.28 -PBDT4.085.27 -23 PBT2.333.87 -40 NP1.672.73 -39Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Dec 13 2017 | 4:58 PM IST